1. Home
  2. EDD vs LFCR Comparison

EDD vs LFCR Comparison

Compare EDD & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDD
  • LFCR
  • Stock Information
  • Founded
  • EDD 2007
  • LFCR 1986
  • Country
  • EDD United States
  • LFCR United States
  • Employees
  • EDD N/A
  • LFCR N/A
  • Industry
  • EDD Finance Companies
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDD Finance
  • LFCR Health Care
  • Exchange
  • EDD Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • EDD 329.4M
  • LFCR 288.0M
  • IPO Year
  • EDD N/A
  • LFCR N/A
  • Fundamental
  • Price
  • EDD $5.30
  • LFCR $6.98
  • Analyst Decision
  • EDD
  • LFCR Buy
  • Analyst Count
  • EDD 0
  • LFCR 4
  • Target Price
  • EDD N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • EDD 254.3K
  • LFCR 217.0K
  • Earning Date
  • EDD 01-01-0001
  • LFCR 10-03-2025
  • Dividend Yield
  • EDD 7.52%
  • LFCR N/A
  • EPS Growth
  • EDD N/A
  • LFCR N/A
  • EPS
  • EDD N/A
  • LFCR N/A
  • Revenue
  • EDD N/A
  • LFCR $128,867,000.00
  • Revenue This Year
  • EDD N/A
  • LFCR $4.71
  • Revenue Next Year
  • EDD N/A
  • LFCR $10.98
  • P/E Ratio
  • EDD N/A
  • LFCR N/A
  • Revenue Growth
  • EDD N/A
  • LFCR 0.47
  • 52 Week Low
  • EDD $4.22
  • LFCR $4.33
  • 52 Week High
  • EDD $4.95
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • EDD 39.65
  • LFCR 42.07
  • Support Level
  • EDD $5.47
  • LFCR $7.00
  • Resistance Level
  • EDD $5.69
  • LFCR $7.55
  • Average True Range (ATR)
  • EDD 0.08
  • LFCR 0.42
  • MACD
  • EDD -0.04
  • LFCR -0.06
  • Stochastic Oscillator
  • EDD 10.95
  • LFCR 21.68

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: